Literature DB >> 3301852

Purification and characterization of human recombinant interleukin-1 beta.

C A Meyers, K O Johanson, L M Miles, P J McDevitt, P L Simon, R L Webb, M J Chen, B P Holskin, J S Lillquist, P R Young.   

Abstract

A human interleukin-1 (IL-1) beta cDNA was cloned, and the region coding for the mature protein was expressed in Escherichia coli. The 17-kDa biologically active product was purified in 40% yield to apparent homogeneity, without chaotropes, from the soluble fraction of sonicated cell lysates. The recombinant IL-1 beta was characterized by amino acid analysis, NH2- and COOH-terminal sequence analysis, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, spectroscopy, and biological assay. Specific biological activity was 4.6 X 10(8) units/mg in a co-mitogenic IL-2 induction assay using cultured EL-4 T-lymphocytes. The molar extinction coefficient was determined to be 10,300 cm-1 M-1 at 280 nm. NH2-terminal sequence analysis revealed that 70% of the product begins with the Ala corresponding to the NH2 terminus of the natural protein, while 30% begins with the following Pro. No initiator Met was observed. Both of the sulfhydryl groups are reactive to Ellman's reagent and to iodoacetamide under nonreducing conditions, indicating that the Cys residues do not form disulfide bonds. S-Carboxamidomethyl-Cys-rIL-1 beta retained biological activity in the IL-2 induction assay. Circular dichroism suggested an extensive beta sheet structure for rIL-1 beta.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301852

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Preparation of Soluble Proteins from Escherichia coli.

Authors:  Paul T Wingfield
Journal:  Curr Protoc Protein Sci       Date:  2014-11-03

2.  Secretion of human serum albumin by Kluyveromyces lactis overexpressing KlPDI1 and KlERO1.

Authors:  Tiziana Lodi; Barbara Neglia; Claudia Donnini
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

3.  Secretion of interleukin-1 beta and Escherichia coli galactokinase by Streptomyces lividans.

Authors:  H Lichenstein; M E Brawner; L M Miles; C A Meyers; P R Young; P L Simon; T Eckhardt
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

4.  Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation.

Authors:  D Rachmilewitz; F Karmeli; L W Schwartz; P L Simon
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

5.  Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.

Authors:  M Ligumsky; P L Simon; F Karmeli; D Rachmilewitz
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

6.  Cytokine production by peripheral blood mononuclear cells from pediatric chronic peritoneal dialysis patients.

Authors:  A M Neu; B A Fivush; H M Lederman
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

7.  Synthesis of a Cys949Tyr alpha 2-macroglobulin thiol ester mutant: co-transfection with wild-type alpha 2-macroglobulin in an episomal expression system.

Authors:  L Van Rompaey; H Van den Berghe; P Marynen
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

8.  Human interleukin 1 beta is not secreted from hamster fibroblasts when expressed constitutively from a transfected cDNA.

Authors:  P R Young; D J Hazuda; P L Simon
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

9.  Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation.

Authors:  E Suzanne Cohen; Ian C Scott; Jayesh B Majithiya; Laura Rapley; Benjamin P Kemp; Elizabeth England; D Gareth Rees; Catherine L Overed-Sayer; Joanne Woods; Nicholas J Bond; Christel Séguy Veyssier; Kevin J Embrey; Dorothy A Sims; Michael R Snaith; Katherine A Vousden; Martin D Strain; Denice T Y Chan; Sara Carmen; Catherine E Huntington; Liz Flavell; Jianqing Xu; Bojana Popovic; Christopher E Brightling; Tristan J Vaughan; Robin Butler; David C Lowe; Daniel R Higazi; Dominic J Corkill; Richard D May; Matthew A Sleeman; Tomas Mustelin
Journal:  Nat Commun       Date:  2015-09-14       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.